These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2852351)

  • 21. Chimeric streptavidins with reduced valencies.
    Lemercier G; Johnsson K
    Nat Methods; 2006 Apr; 3(4):247-8. PubMed ID: 16554826
    [No Abstract]   [Full Text] [Related]  

  • 22. DNA vaccine design.
    Brandsma JL
    Methods Mol Med; 2006; 127():3-10. PubMed ID: 16988442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [C1 and cro repressors of lambda phages. I. Construction of vectors for expression of cro repressor of bacteriophage lambda imm434].
    Bespalova IN; Rubtsov PM; Kirpichnikov MP; Skriabin KG
    Mol Biol (Mosk); 1984; 18(1):30-8. PubMed ID: 6323976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of oligonucleotide directed cleavage of DNA and homologous recombination in the production of large recombinant adenoviral vectors.
    Castro-Peralta F; Villarreal LP
    Gene Ther; 2000 Apr; 7(7):583-6. PubMed ID: 10819573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The segmented paper method: DNA synthesis and mutagenesis by rapid microscale "shotgun gene synthesis".
    Matthes HW; Staub A; Chambon P
    Methods Enzymol; 1987; 154():250-87. PubMed ID: 2828854
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of gene transfer to increase animal growth.
    Hammer RE; Brinster RL; Palmiter RD
    Cold Spring Harb Symp Quant Biol; 1985; 50():379-87. PubMed ID: 3006997
    [No Abstract]   [Full Text] [Related]  

  • 27. The recombinant DNA scenarios: Andromeda strain, chimera, and Golem.
    Davis BD
    Jpn J Antibiot; 1977 Dec; 30 Suppl():262-74. PubMed ID: 349193
    [No Abstract]   [Full Text] [Related]  

  • 28. Chimeric gene construction without reference to restriction sites.
    Shigaki T; Hirschi KD
    Biotechniques; 2002 Apr; 32(4):736, 738, 740. PubMed ID: 11962592
    [No Abstract]   [Full Text] [Related]  

  • 29. Unbottling the genes.
    Nat Biotechnol; 2009 Dec; 27(12):1059. PubMed ID: 20010557
    [No Abstract]   [Full Text] [Related]  

  • 30. Designer genes.
    Nature; 1981 Mar; 290(5801):11-2. PubMed ID: 6259531
    [No Abstract]   [Full Text] [Related]  

  • 31. Essential information for synthetic DNA sequences.
    Peccoud J; Anderson JC; Chandran D; Densmore D; Galdzicki M; Lux MW; Rodriguez CA; Stan GB; Sauro HM
    Nat Biotechnol; 2011 Jan; 29(1):22; discussion 22-3. PubMed ID: 21221092
    [No Abstract]   [Full Text] [Related]  

  • 32. Development and engineering of artificial RNAs.
    Ryckelynck M
    Methods; 2019 May; 161():1-2. PubMed ID: 31195094
    [No Abstract]   [Full Text] [Related]  

  • 33. [Genetic engineering (I). An unconventional method for the construction of a new species].
    Rörsch A
    Ned Tijdschr Tandheelkd; 1977; 84(7-8):237-41. PubMed ID: 275599
    [No Abstract]   [Full Text] [Related]  

  • 34. New method to repair faulty genes stirs interest in chimeraplasty technique.
    Stephenson J
    JAMA; 1999 Jan; 281(2):119-21. PubMed ID: 9917100
    [No Abstract]   [Full Text] [Related]  

  • 35. Transgenic plants.
    Horsch RB; Rogers SG; Fraley RT
    Cold Spring Harb Symp Quant Biol; 1985; 50():433-7. PubMed ID: 3868487
    [No Abstract]   [Full Text] [Related]  

  • 36. Powerful new tools in genetics.
    Comings DE
    Am J Hum Genet; 1979 Sep; 31(5):647-8. PubMed ID: 292308
    [No Abstract]   [Full Text] [Related]  

  • 37. Chimeric vector construction for higher-plant transformation.
    Balázs E; Bouzoubaa S; Guilley H; Jonard G; Paszkowski J; Richards K
    Gene; 1985; 40(2-3):343-8. PubMed ID: 3007300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A general method for construction of chimeric genes.
    Kanda T; Saigo K
    Nucleic Acids Symp Ser; 1988; (19):157-60. PubMed ID: 2852351
    [No Abstract]   [Full Text] [Related]  

  • 39. [General approach to the engineering of synthetic DNA].
    Chakhmakhcheva OG; Buriakova AA; Mirskikh OV; Reverdatto SV; Efimov VA
    Bioorg Khim; 1985 Nov; 11(11):1533-46. PubMed ID: 3004509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [EcoR1 restriction in vivo: possible utilization in genetic engineering].
    Skavronskaia AG; Aleshkin GI; Demkin VV; Strikhanov SN; Evdokimova NM
    Vestn Akad Med Nauk SSSR; 1981; (2):40-6. PubMed ID: 6264708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.